| 标题： | 原发性中枢神经系统淋巴瘤临床实践指南 |
| title： | Clinical Practice Guideline on Primary Central Nervous System Lymphoma |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 标准指南 |
| classification： | Standard guideline |
| 领域： | 综合 |
| field： | Comprehensive guideline |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 临床医师、临床药师和护师 |
| Guide users： | Clinical professionals (including clinical practitioners, pharmacists and nurses) |
| 证据分级方法： | Grading of Recommendations, Assessment, Development and Evaluations, GRADE |
| Evidence grading method： | |
| 制定单位： | 中华医学会神经外科学分会，中国抗癌协会血液肿瘤专业委员会 |
| Formulating unit： | The Chinese Neurosurgical Society of the Chinese Medical Association, The Society of Hematological malignancies of China Anti-Cancer Association |
| 注册时间： | 2021-01-01 |
| Registration time： | |
| 注册编号： | IPGRP-2021CN001 |
| Registration number： | |
| 指南制订的目的： | 本指南按照循证临床实践指南制订的标准方法与步骤，旨在进一步促进原发性中枢神经系统淋巴瘤的规范诊疗，为相关临床医生及医务人员提供科学、具体的指导。 |
| Purpose of the guideline： | This guideline followed the standard method and process of developing an evidence-based clinical practice guideline, aims to standardize the diagnosis and treatment of primary central nervous system lymphoma, and provides the appropriate support for health workers and practitioners in the field of primary central nervous system lymphoma. |
最新注册
